what is glp-1 micro dosing Why Microdosing? A Closer Look at Reported Benefits Micro-dosing' GLP-1 drugs is a

FDA-Labeled Indications for Chronic Weight Management As of early 2026, two medications carry FDA indications specifically for chronic weight management in adults: Wegovy (semaglutide 2.4 mg) approved 2021 Zepbound (tirzepatide) approved 2023 Liraglutide (Saxenda) is also approved for weight management but has been largely supplanted by the once-weekly options

GLP-1 medications fall neatly into the four pillars of obesity care management, Alexander and Basilico both said

As such, effective management of obesity requires a personalized, multidisciplinary approach combining behavioral and dietary interventions, pharmacological therapies, physical activity, and surgery

Common side effects include nausea, diarrhea, and constipation usually subsiding over time

Some evidence suggests dual agonists might better preserve lean body mass during weight loss, though this remains under investigation

It is whether we can lose the right weight